Development of Age‐ and Sex‐Specific Metabolomics‐Based Biological Ageing Clocks for 10‐Year Mortality Prediction
Advanced Science · 2026
DOI: 10.1002/advs.202510189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lei Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. Hauptthemen laut MEDLINE: Metabolomics, Aging, Mortality, Biological Clocks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Metabolite concentrations vary by age and sex, yet age‐ and sex‐specific metabolomic risk scores and biological ageing clocks for mortality prediction remain undeveloped. Nuclear magnetic resonance (NMR)‐based metabolomic profiling is conducted in 209144 UK Biobank participants (12347 deaths) and 6820 from the German ESTHER study (804 deaths). Mortality risk scores are derived using least absolute shrinkage and selection operator (LASSO)‐regularized Cox regression, and metabolomics‐based mortality risk clocks (MetaboMR clocks) are constructed using elastic net regression in sex‐ and age‐stratified subgroups (50–59 and 60–69 years). Models are trained in 70% of UK Biobank and validated internally (30%) and externally in ESTHER. 68 metabolites are significantly associated with 10‐year all‐cause mortality in both cohorts. 20, 18, 12, and 13 metabolites improved 10‐year mortality prediction in younger and older men, younger and older women. Metabolite‐augmented models improved c‐statistics by 0.036–0.084 across subgroups. In the external validation set, each year of age acceleration is associated with an 8% and 9% higher 10‐year mortality risk for MetaboMR clock1 and clock2. Sex‐ and age‐specific metabolomic risk scores significantly enhance 10‐year mortality prediction beyond traditional models. The MetaboMR clocks may serve as measures of biological ageing and support personalized risk stratification in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.
- Faculty of Medicine, University of Heidelberg, Im Neuenheimer Feld 672, 69120, Heidelberg, Germany.
- Saarland Cancer Registry, Neugeländstraße 9, 66117, Saarbrücken, Germany.
- Division of Preventive Oncology, German Cancer Research Center, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
Förderung
- Wellcome Trust
Zitieren
APA
Peng, L., Xie, R., Holleczek, B., Brenner, H., & Schöttker, B. (2026). Development of Age‐ and Sex‐Specific Metabolomics‐Based Biological Ageing Clocks for 10‐Year Mortality Prediction. Advanced Science. https://doi.org/10.1002/advs.202510189
Vancouver
Peng L, Xie R, Holleczek B, Brenner H, Schöttker B. Development of Age‐ and Sex‐Specific Metabolomics‐Based Biological Ageing Clocks for 10‐Year Mortality Prediction. Advanced Science. 2026. doi:10.1002/advs.202510189
BibTeX
@article{Peng2026,
author = {Peng, Lei and Xie, Ruijie and Holleczek, Bernd and Brenner, Hermann and Schöttker, Ben},
title = {Development of Age‐ and Sex‐Specific Metabolomics‐Based Biological Ageing Clocks for 10‐Year Mortality Prediction},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202510189}
}
EUVIMED